MyoStrain
Commercial- Indications
- Cardiovascular disease, Heart failure, Cardiotoxicity
Company intelligence / Profile preview
MyoStrain® is a rapid, non-invasive MRI-based diagnostic test that quantifies subtle changes in heart muscle function within 10 minutes, without contrast agents or radiation. It has been validated with over 80,000 patient data points from more than 70 medical centers and supported by over 500 publications. The technology enables early detection and proactive management of cardiac dysfunction—especially valuable for at-risk populations such as oncology patients receiving potentially cardiotoxic therapies.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Myocardial Solutions.